These cancers include CNS tumors such as optic glioma and astrocytoma resulting from NF1 mutations, and osteosarcoma, soft-tissue sarcoma and ACT resulting from TP53 mutations. This evidence concerns the gene TP53 and soft tissue sarcoma.